Sponsor Pipeline

Myungmoon Pharma. Co. Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07016269
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary…
date change Primary completion pushed: 2026-06 -> 2027-11-10
2026-07-30 NCT07016269
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary…
date change Completion pushed: 2026-06 -> 2028-06-13
2026-07-30 NCT07005752
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With…
Trial sites expanded: 6 -> 13 locations
2026-07-30 NCT07005752
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With…
date change Primary completion pushed: 2026-06 -> 2027-11-10
2026-07-30 NCT07005752
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With…
date change Completion pushed: 2026-06 -> 2028-06-13
Active Trials by Phase
Phase 4
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07005752 A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With… Cholesterol Cholelithiasis Recruiting
NCT07016269 A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary… Biliary Dyspepsia Recruiting
Get alerts when Myungmoon Pharma. Co. Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free